Search for: "Watson v. Denmark" Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jun 2023, 1:57 pm by Elin Hofverberg
Soon Gustav gathered a group of men from Dalarna, who in Västerås fought all the Danes to flee, and asked archbishop Gustav to not use his troops against his own people but instead against the enemies of the church; but he did not listen and became the enemy of the prince; was banished and sent to Denmark. [read post]
22 Mar 2019, 6:27 am
Posted by Cydney Posner, Cooley LLP, on Sunday, March 17, 2019 Tags: Accountable Capitalism Act, Citizens United v. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
5 Oct 2011, 3:44 am by Marie Louise
  General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
5 Oct 2011, 3:44 am by Marie Louise
  General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
11 Aug 2014, 4:24 am by Ben
 Automated Solutions Corporation v. [read post]
27 Jul 2011, 1:01 am by Marie Louise
  Highlights this week included: Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
15 Nov 2010, 4:18 am by Kelly
Wheel Pros, Inc., et. al.; Mintz v Dietz and Watson (Docket Report) District Court N D Illinois: False marking case dismissed with prejudice for failure to plead intent: McNamara v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
24 Apr 2017, 8:33 am by Quinta Jurecic
Sometimes, the occasion is run-of-the-mill official business, such as a photograph of Trump’s meeting with the Prime Minister of Denmark, but things can get more complicated. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
6 Jun 2008, 6:49 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: YouTube – Prince demands removal of song from YouTube, Radiohead demand it is put back online: (Techdirt), (Electronic Frontier Foundation), (The Trademark Blog), Japan planning fair use provision: (Michael Geist), (Techdirt), (IP Justice), (Patry Copyright Blog), Judge rejects Yoko Ono’s request for preliminary injunction… [read post]
29 Jan 2024, 4:35 pm
v=BxL9DRdk6Xc   New Animation: End Hare Coursing In a world where compassion and empathy should be our guiding principles, it is disheartening to discover that some individuals derive enjoyment and profit from the suffering of innocent creatures. [read post]
2 Jul 2013, 1:41 pm
The other day, I was blogging about tags, and somebody asked what are all the tags. [read post]